TrademarkDir
EPIDIOLEX
LIVE

Serial Number

79156538

Owner

Jazz Pharmaceuticals Research UK Limited

Attorney

Michael T. Olsen

Filing Date

Aug 14, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EPIDIOLEX Trademark

Serial Number: 79156538 • Registration: 4838876

EPIDIOLEX is a trademark filed by Jazz Pharmaceuticals Research UK Limited on August 14, 2014. The trademark is classified under Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Trademark Details

Filing Date

August 14, 2014

Registration Date

October 27, 2015

Published for Opposition

August 11, 2015

Cancellation Date

May 13, 2022

Goods & Services

Agricultural and horticultural products, namely, fruit seeds, flowers and live plants

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2025 ADCH
GENERIC MADRID TRANSACTION SENT TO IB
Feb 28, 2025 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 28, 2025 INNA
GENERIC MADRID TRANSACTION CREATED
Feb 28, 2025 XXCR
INTERNATIONAL REGISTRATION RENEWED
Sep 13, 2024 RNWL
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 13, 2023 INTR
CANCELLED SECTION 71
May 13, 2022 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2021 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 15, 2021 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 27, 2020 REM3
CHANGE OF OWNER RECEIVED FROM IB
Aug 30, 2018 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Dec 21, 2017 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 29, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 29, 2017 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 7, 2016 FICS
FINAL DISPOSITION PROCESSED
Mar 7, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 27, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2015 R.PR
NOTIFICATION PROCESSED BY IB
Aug 21, 2015 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2015 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 5, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 5, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 6, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2015 CRFA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2015 REAP
ASSIGNED TO LIE
Jun 25, 2015 ALIE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 19, 2015 ADCH
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2015 TROA
REFUSAL PROCESSED BY IB
Jan 8, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 23, 2014 RFCS
REFUSAL PROCESSED BY MPU
Dec 23, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 21, 2014 RFCR
NON-FINAL ACTION WRITTEN
Dec 20, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 16, 2014 MAFR
ASSIGNED TO EXAMINER
Dec 12, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 11, 2014 REPR

Related Trademarks

More from this Owner

EPIFOS

EPIFOS

EPIDYOLEX

EPIDYOLEX

LIVINGWITH

LIVINGWITH

LIVINGWITH

LIVINGWITH

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT logo

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT logo

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT